![1346602-09-2 | Oxiracetam-13C2,15N | 4-Hydroxy-2-oxo-1-pyrrolidineacetamide-13C2,15N; Hydroxypiracetam-13C2,15N; 2-(4-Hydroxy-2-oxopyrrolidin-1-yl)acetamide-13C2,15N; CGP 21690-13C2,15N; CGP 21690E-13C2,15N; CT 848-13C2,15N; 4-Hydroxy-2-oxo-1 ... 1346602-09-2 | Oxiracetam-13C2,15N | 4-Hydroxy-2-oxo-1-pyrrolidineacetamide-13C2,15N; Hydroxypiracetam-13C2,15N; 2-(4-Hydroxy-2-oxopyrrolidin-1-yl)acetamide-13C2,15N; CGP 21690-13C2,15N; CGP 21690E-13C2,15N; CT 848-13C2,15N; 4-Hydroxy-2-oxo-1 ...](https://www.trc-canada.com/prod-img/O846907.png)
1346602-09-2 | Oxiracetam-13C2,15N | 4-Hydroxy-2-oxo-1-pyrrolidineacetamide-13C2,15N; Hydroxypiracetam-13C2,15N; 2-(4-Hydroxy-2-oxopyrrolidin-1-yl)acetamide-13C2,15N; CGP 21690-13C2,15N; CGP 21690E-13C2,15N; CT 848-13C2,15N; 4-Hydroxy-2-oxo-1 ...
![62613-82-5 | Oxiracetam | 4-Hydroxy-2-oxo-1-pyrrolidineacetamide; Hydroxypiracetam; 2-(4-Hydroxy-2-oxopyrrolidin-1-yl)acetamide; CGP 21690; CGP 21690E; CT 848; 4-Hydroxy-2-oxo-1-pyrrolidineacetamide; 4-Hydroxypyrrolidone-2-acetamide; | C₆H₁₀N₂O₃ | TRC 62613-82-5 | Oxiracetam | 4-Hydroxy-2-oxo-1-pyrrolidineacetamide; Hydroxypiracetam; 2-(4-Hydroxy-2-oxopyrrolidin-1-yl)acetamide; CGP 21690; CGP 21690E; CT 848; 4-Hydroxy-2-oxo-1-pyrrolidineacetamide; 4-Hydroxypyrrolidone-2-acetamide; | C₆H₁₀N₂O₃ | TRC](https://www.trc-canada.com/prod-img/O846905.png)
62613-82-5 | Oxiracetam | 4-Hydroxy-2-oxo-1-pyrrolidineacetamide; Hydroxypiracetam; 2-(4-Hydroxy-2-oxopyrrolidin-1-yl)acetamide; CGP 21690; CGP 21690E; CT 848; 4-Hydroxy-2-oxo-1-pyrrolidineacetamide; 4-Hydroxypyrrolidone-2-acetamide; | C₆H₁₀N₂O₃ | TRC
![2-(2-Oxo-morpholin-3-yl)-acetamide Derivatives as Broad-Spectrum Antifungal Agents | Journal of Medicinal Chemistry 2-(2-Oxo-morpholin-3-yl)-acetamide Derivatives as Broad-Spectrum Antifungal Agents | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/jm501814x/asset/images/large/jm-2014-01814x_0016.jpeg)
2-(2-Oxo-morpholin-3-yl)-acetamide Derivatives as Broad-Spectrum Antifungal Agents | Journal of Medicinal Chemistry
Analytics for US Patent No. 6969770, 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
![103765-01-1 | (R)-Levetiracetam | (αR)-α-Ethyl-2-oxo-1-pyrrolidineacetamide; (R)-α-ethyl-2-oxo-1-pyrrolidineacetamide; (2R)-2-(2-Oxo-pyrrolidin-1-yl)butanamide; UCB-L 060; Levetiracetam EP Impurity D | C₈H₁₄N₂O₂ | TRC 103765-01-1 | (R)-Levetiracetam | (αR)-α-Ethyl-2-oxo-1-pyrrolidineacetamide; (R)-α-ethyl-2-oxo-1-pyrrolidineacetamide; (2R)-2-(2-Oxo-pyrrolidin-1-yl)butanamide; UCB-L 060; Levetiracetam EP Impurity D | C₈H₁₄N₂O₂ | TRC](https://www.trc-canada.com/prod-img/L331505.png)
103765-01-1 | (R)-Levetiracetam | (αR)-α-Ethyl-2-oxo-1-pyrrolidineacetamide; (R)-α-ethyl-2-oxo-1-pyrrolidineacetamide; (2R)-2-(2-Oxo-pyrrolidin-1-yl)butanamide; UCB-L 060; Levetiracetam EP Impurity D | C₈H₁₄N₂O₂ | TRC
![7491-74-9 | Piracetam | 2-Oxo-1-pyrrolidineacetamide; (2-Oxopyrrolidino) acetamide; 2-(2-Oxopyrrolidin-1-yl)acetamide; Avigilen; Axonyl; Cerebroforte; Piramem; Pyracetam; UCB 6215; | C₆H₁₀N₂O₂ | TRC 7491-74-9 | Piracetam | 2-Oxo-1-pyrrolidineacetamide; (2-Oxopyrrolidino) acetamide; 2-(2-Oxopyrrolidin-1-yl)acetamide; Avigilen; Axonyl; Cerebroforte; Piramem; Pyracetam; UCB 6215; | C₆H₁₀N₂O₂ | TRC](https://www.trc-canada.com/prod-img/P500800.png)
7491-74-9 | Piracetam | 2-Oxo-1-pyrrolidineacetamide; (2-Oxopyrrolidino) acetamide; 2-(2-Oxopyrrolidin-1-yl)acetamide; Avigilen; Axonyl; Cerebroforte; Piramem; Pyracetam; UCB 6215; | C₆H₁₀N₂O₂ | TRC
![Characterization and Crystal Nucleation Kinetics of a New Metastable Polymorph of Piracetam in Alcoholic Solvents | Crystal Growth & Design Characterization and Crystal Nucleation Kinetics of a New Metastable Polymorph of Piracetam in Alcoholic Solvents | Crystal Growth & Design](https://pubs.acs.org/cms/10.1021/acs.cgd.1c01421/asset/images/medium/cg1c01421_0001.gif)